Surgery Alone for Bone Cancer

Phase-Based Progress Estimates
Mount Sinai Hospital, Toronto, CanadaBone Cancer+2 MoreSurgery Alone - Procedure
All Sexes
What conditions do you have?

Study Summary

This trial will help researchers understand how best to treat femoral metastases, specifically those at high risk of pathological fracture.

Eligible Conditions
  • Metastatic Bone Cancer
  • Risk of Fracture
  • Cancer

Treatment Effectiveness

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: 6 months

6 months
To describe patient and disease characteristics of major management groups (surgery ± radiotherapy, radiotherapy alone due to preference, radiotherapy alone due to co-morbid conditions) - Assessment of lower limb function
To describe patterns of management in patients with femoral metastases at high risk of pathological fracture - Perioperative Morbidity and Mortality for surgical patients; pain score and performance status; QOL
To describe the ambulatory status at 3 months by intervention (surgery ± radiotherapy, and radiotherapy alone group) - Ambulatory status

Trial Safety

Trial Design

2 Treatment Groups

Surgery Alone
1 of 2
Surgery + Radiation Therapy
1 of 2

Active Control

180 Total Participants · 2 Treatment Groups

Primary Treatment: Surgery Alone · No Placebo Group · N/A

Surgery Alone
ActiveComparator Group · 1 Intervention: Surgery Alone · Intervention Types: Procedure
Surgery + Radiation Therapy
ActiveComparator Group · 1 Intervention: Combined Surgery and Radiation therapy · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,386 Previous Clinical Trials
471,814 Total Patients Enrolled
Rebecca Wong, MB ChBPrincipal InvestigatorUniversity Health Network, Princess Margaret Hospital
Peter Ferguson, MDPrincipal InvestigatorMount Sinai Hospital, Canada
1 Previous Clinical Trials
20 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

How many participants have registered for this clinical trial?

"Absolutely. According to the listing, this study initiated recruitment on March 1st 2009 and has been recently updated as of October 6th 2022. This medical trial is currently requesting 180 patients for participation at two separate sites." - Anonymous Online Contributor

Unverified Answer

Are new participants still eligible to join this research experiment?

"Indeed, confirms that this medical trial remains open to applicants. Originally posted on March 1st 2009 and updated October 6th 2022, the study is targeting 180 patients across two research centres." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.